# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Swami Vivekananda (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI032-SYN-TD
- Date: 1898-02-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anjali Thornbury-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Diagnosis visit: fasting test results with the endocrinology consultation. **S**

## History of present illness

Swami Vivekananda returns one week after his first visit, fasting since the evening meal, for blood tests drawn this morning and his consultation with Dr. Lindqvist-Bose. He is still thirsty and passes urine three times a night. He has drunk water freely as advised. A few days ago he kept the night-long fast of a major festival, without water until the next morning, and felt light-headed and very thirsty by dawn; he asked how he can keep his fasts safely. His home blood pressure readings over the week averaged 136/86. He wants to know what kind of diabetes this is and whether he will need injections. **S**

| Element | Detail |
|---|---|
| Symptoms | Thirst; nocturia three times; tiredness; weight 72.8 kg |
| Fasting | A night-long waterless festival fast a few days ago, with light-headedness by dawn |
| Home blood pressure | Average 136/86 over seven days |
| His questions | What kind of diabetes, whether injections are needed, and how to keep his fasts |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; weight down a further 0.2 kg |
| Genitourinary | Positive | Frequent urination, three times a night |
| Eyes | Positive | Reading vision blurred at times |
| Gastrointestinal | Negative | No abdominal pain, nausea or vomiting |
| Neurological | Negative | No numbness or tingling |

5 systems reviewed. **S**

## Current medications

- Metformin extended-release 500 mg tablets: two tablets (1000 mg) with the evening meal, starting with one for the first week **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/86 mmHg; pulse 80 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 72.8 kg; BMI 24.6 kg/m². All vital signs are synthetic.

Hemoglobin A1c: 9.4% (high); Glucose (fasting): 172 mg/dL (high); GAD65 antibodies: 1.2 [IU]/mL; C-peptide (fasting): 2.6 ng/mL; Urine albumin-to-creatinine ratio: 46 mg/g (high); Total cholesterol: 214 mg/dL (high); HDL cholesterol: 36 mg/dL (low); Triglycerides: 228 mg/dL (high); LDL cholesterol: 132 mg/dL (high); ALT: 38 U/L; TSH: 1.8 mIU/L; Vitamin B12: 312 pg/mL. All results are synthetic.

## Change since baseline

- Glucose (fasting): 246 mg/dL (high) at baseline, 172 mg/dL (high) at this visit **S**

## Immunizations given today

- Influenza vaccine, this season **S**
- COVID-19 mRNA vaccine, this season's formula **S**
- Pneumococcal conjugate vaccine PCV20 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well, alert and forthright; weight 72.8 kg, BMI 24.6; blood pressure 136/86, pulse 80 |
| Skin | No acanthosis nigricans; mucous membranes moist |
| Feet | Skin intact; pulses present; monofilament and vibration sense normal |
| Cardiovascular | Regular rhythm; no edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Type 2 diabetes, new** (E11.65). Diabetes is confirmed by two abnormal results, A1c 9.4 percent and fasting glucose 172 mg/dL, with symptoms. GAD65 antibodies are negative and the fasting C-peptide of 2.6 ng/mL shows good insulin secretion, so this is type 2 diabetes, not type 1 or slowly progressive autoimmune diabetes; his urine had no ketones. South Asian people develop type 2 diabetes younger and at lower weights, which is why ADA screens Asian Americans from a BMI of 23; his BMI is 24.6. Insulin is not needed now: there is no ketosis, his own insulin is preserved and the A1c is below 10 percent. After discussing metformin alone, metformin with a second tablet, and an injected GLP-1 receptor agonist, he chose to start with metformin and diet and to review in five weeks. **S**
   - Metformin extended-release 500 mg with the evening meal for a week, then 1000 mg.
   - Home glucose meter: fasting reading daily, and during any fast.
   - Dietitian and diabetes education this week.
   - Target A1c below 7 percent.
2. **Religious fasting with diabetes**. Fasting is his practice and his decision. Using IDF-DAR risk stratification adapted to his fasts, his risk is moderate: on metformin alone hypoglycemia is unlikely, but with glucose this high a fast without water risks dehydration, as he felt last week. **S**
   - Fortnightly fasts with fruit, milk and water are reasonable now; avoid fasts without water until his glucose is steady below 180 mg/dL.
   - Take metformin with the meal that ends a fast.
   - Check glucose at midday and before breaking the fast; break the fast if below 70 or above 300 mg/dL, or if dizzy, confused or vomiting.
3. **Moderately increased albuminuria, first sample** (R80.9). Urine albumin-to-creatinine ratio 46 mg/g with a normal eGFR; it can rise with very high glucose, so it must be repeated twice over three to six months. **S**
   - Repeat at the next visit and in three months.
4. **Raised blood pressure** (R03.0). Clinic 136/86 and home 136/86: hypertension is likely; with albuminuria the target is below 130/80. **S**
   - Decide on treatment at the preventive visit after another week of home readings.
5. **Mixed hyperlipidemia** (E78.2). LDL 132, triglycerides 228 and HDL 36; triglycerides will fall as glucose improves. **S**
   - Discuss a statin at the preventive visit.
6. **Insomnia** (G47.00). Lifelong difficulty falling asleep, worse with nocturia from high glucose. **S**
   - Sleep diary; cognitive behavioral therapy for insomnia referral.
7. **Hyperglycemia with thirst and weight loss** (R73.9). Explained by the diagnosis made today; superseded. **S**
   - Problem resolved.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | A1c and fasting glucose | At diagnosis; quarterly until at goal | Completed today | A1c 9.4 percent; fasting glucose 172 mg/dL |
| Laboratory | Classification: GAD65 antibodies and C-peptide | At diagnosis when type 1 or autoimmune diabetes is possible (young, lean or weight loss) | Completed today | GAD65 antibodies 1.2 IU/mL (negative); C-peptide 2.6 ng/mL (preserved); urine ketones negative last week |
| Laboratory | Urine albumin-to-creatinine ratio and eGFR | At diagnosis, then yearly; two of three abnormal over three to six months to confirm | Completed today | 46 mg/g, moderately increased; eGFR 106 last week |
| Laboratory | Lipid panel | At diagnosis | Completed today | LDL 132, triglycerides 228, HDL 36 |
| Laboratory | ALT with FIB-4 (fatty liver screen) and TSH | At diagnosis | Completed today | ALT 38; FIB-4 0.6 (low risk); TSH 1.8 |
| Laboratory | Vitamin B12 | Periodically on long-term metformin; baseline because he eats mostly vegetarian food | Completed today | 312 pg/mL, normal |
| Examination | Blood pressure, weight and BMI | Every visit | Completed today | 136/86; home 136/86; weight 72.8 kg, BMI 24.6 |
| Examination | Comprehensive foot examination | At diagnosis, then yearly | Completed today | Normal monofilament and vibration; pulses present |
| Referral | Dilated eye examination or retinal photographs | At diagnosis, then every one to two years | Ordered | Retinal photographs booked for the next visit |
| Self-management | Diabetes self-management education and medical nutrition therapy | At diagnosis | Referred | Dietitian this week: a mostly vegetarian plan built on his monastery meals |
| Self-management | Fasting risk assessment and plan | Before any religious fast | Completed today | Moderate risk; plan for fruit-and-milk fasts; no waterless fasts until glucose is steady |
| Medication safety | Hypoglycemia review | Every visit on insulin or a sulfonylurea | Not indicated | Neither used; sulfonylureas avoided because of his fasting |
| Self-management | Tobacco use | Every visit | Completed today | None now |
| Survey | Depression, anxiety and diabetes distress | At diagnosis and yearly | Up to date | PHQ-2 0 last week; full screens at the preventive visit |
| Self-management | Vaccinations | Yearly | Completed today | Influenza, COVID-19 and PCV20 today; hepatitis B and Tdap at the preventive visit |

## Goal progress

- Diabetes confirmed and classified within a week. Outcome by 1898-02-16: Type 2 diabetes confirmed by A1c 9.4 percent and fasting glucose 172 mg/dL; GAD65 antibodies negative and C-peptide preserved. **S**
- A1c below 7 percent without hypoglycemia, in a way that fits his diet and fasts. In progress; target 1898-10-27. **S**
- Blood pressure below 130/80. In progress; target 1898-03-23. **S**
- Albuminuria reduced and kidney function preserved. In progress; target 1899-01-26. **S**
- Falling asleep within 30 minutes on most nights. In progress; target 1898-12-08. **S**

## Medication changes

- Started: Metformin extended-release 500 mg tablets: two tablets (1000 mg) with the evening meal, starting with one for the first week **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026), Aether Forge
- 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1):S27-S49)
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- Gujral UP, et al. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63 (PMID 23317344) (2013), Annals of the New York Academy of Sciences
- Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991) (2021), International Diabetes Federation and the Diabetes and Ramadan International Alliance

## Follow-up

- Preventive visit in three weeks. Diabetes review in five weeks, with retinal photographs and the repeat urine albumin. Call for vomiting, abdominal pain, drowsiness or glucose above 300 mg/dL. **S**
- Next scheduled visit 1898-03-09: periodic preventive visit. **S**
